4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tempest Therapeutics, Inc. (TPST) operates in the Biotechnology industry and is headquartered in Brisbane, United States with about 5 employees. Its market capitalization is roughly $16 million. In the fiscal year ended 2025-12-31, TPST reported $0M in revenue and ($26M) in net income.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($27M) | ($42M) | ($29M) | ($35M) | — |
| Net Income | ($26M) | ($42M) | ($30M) | ($36M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($28M) | ($4M) | ($4M) | ($8M) | ($11M) |
| Net Income | ($28M) | ($4M) | ($4M) | ($8M) | ($11M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $17M | $42M | $52M | $46M | — |
| Total Liabilities | $10M | $22M | $25M | $28M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TPST viewer.
About TickerBase · Data methodology & sources